savarapharma.com | Savara Inc. | Clinical-stage Biopharmaceutical Company

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php

Meta Tags

Title	Savara Inc. \| Clinical-stage Biopharmaceutical Company \| Rare Respiratory
Description	Breathing new life into the treatment of autoimmune pulmonary alveolar proteinosis Savara is a clinical-stage biopharmaceutical company focused on rare respiratory
Keywords	N/A

Server Information

WebSite	savarapharma.com
Host IP	104.198.15.88
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

savitude.squarespace.com

savoypizzeria.com

savvassuccessnet.com

savvastjortjoglou.com

savarapharma.com Valuation

US$11,010,303

Last updated: 2022-06-18 19:02:01

savarapharma.com has Semrush global rank of 961,309. savarapharma.com has an estimated worth of US$ 11,010,303, based on its estimated Ads revenue. savarapharma.com receives approximately 1,270,420 unique visitors each day. Its web server is located in United States, with IP address 104.198.15.88. According to SiteAdvisor, savarapharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$11,010,303
Daily Ads Revenue	US$10,164
Monthly Ads Revenue	US$304,901
Yearly Ads Revenue	US$3,658,809
Daily Unique Visitors	84,695
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
savarapharma.com.	A	3599	IP: 104.198.15.88
savarapharma.com.	NS	7200	NS Record: ns36.worldnic.com.
savarapharma.com.	NS	7200	NS Record: ns35.worldnic.com.
savarapharma.com.	MX	3600	MX Record: 0 savarapharma-com.mail.protection.outlook.com.
savarapharma.com.	TXT	7200	TXT Record: spycloud-domain-verification=939be02820d0f7ad3aaf4355d2d21b52675f72de
savarapharma.com.	TXT	3600	TXT Record: adobe-idp-site-verification=69f94485eb47d92026d05e0d722c723137b66b6aabac342824a315a409349ae7
savarapharma.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com ip4:192.254.121.248 include:_phishspf.knowbe4.com include:spf.mandrillapp.com -all

HtmlToTextCheckTime:2022-06-18 19:02:01

About Savara Our Company About Savara Management Board of Directors Clinical Advisory Board Careers Our Science aPAP aPAP Background In Development Molgramostim in aPAP Clinical Trials Articles & Publications Investors Press Releases Events & Presentations Stock Information SEC Filings Analyst Coverage Corporate Governance Contact Breathing new life into the treatment of autoimmune pulmonary alveolar proteinosis (aPAP) About Savara Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Learn about Savara Our Science Our science is fueled by our desire to provide improved treatment options to people living with rare respiratory diseases. More about our indication In Development Our lead product candidate, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). What’s in development Information for Investors View

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 22 Oct 2021 16:15:08 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://savarapharma.com/
Access-Control-Allow-Origin: savara.local
Access-Control-Allow-Origin: savara.gcs-web.com
Access-Control-Allow-Origin: 5558991.nasdaq.acsitetest.com

HTTP/2 200 
server: nginx
date: Fri, 22 Oct 2021 16:15:08 GMT
content-type: text/html; charset=UTF-8
content-length: 65795
vary: Accept-Encoding
vary: Accept-Encoding
x-pingback: https://savarapharma.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 4
x-cache-group: normal
accept-ranges: bytes
access-control-allow-origin: savara.local
access-control-allow-origin: savara.gcs-web.com
access-control-allow-origin: 5558991.nasdaq.acsitetest.com

savarapharma.com Whois Information

Domain Name: SAVARAPHARMA.COM
Registry Domain ID: 1489182025_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-04-08T07:51:51Z
Creation Date: 2008-06-07T22:36:13Z
Registry Expiry Date: 2025-06-07T22:36:13Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS35.WORLDNIC.COM
Name Server: NS36.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T06:31:19Z <<<

savarapharma.com valuation and analysis